1-14 of 14
Stefan Stevanovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1493: Discovery and CAR T targeting of lineage-restricted neuroblastoma oncoproteins

Mark Yarmarkovich, John M. Warrington, Quinlen F. Marshall, Helena Shen, Wei Li, Matt Beasley, Moreno Di Marco, Stefan Stevanovic, Nikolaos G. Sgourakis, Dimiter Dimitrov, Peter Smith, John M. Maris
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1493.
https://doi.org/10.1158/1538-7445.AM2021-1493
Published: 01 July 2021
View articletitled, Abstract 1493: Discovery and CAR T targeting of lineage-restricted neuroblastoma oncoproteins
Journal Articles

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

Markus W. Löffler, Daniel J. Kowalewski, Linus Backert, Jörg Bernhardt, Patrick Adam, Heiko Schuster, Florian Dengler, Daniel Backes, Hans-Georg Kopp, Stefan Beckert, Silvia Wagner, Ingmar Königsrainer, Oliver Kohlbacher, Lothar Kanz, Alfred Königsrainer, Hans-Georg Rammensee, Stefan Stevanović, Sebastian P. Haen
Journal: Cancer Research
Cancer Res (2018) 78 (16): 4627–4641.
https://doi.org/10.1158/0008-5472.CAN-17-1745
Published: 14 August 2018
View articletitled, Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation
Open the PDF for Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation in another window
Includes: Supplementary data
Journal Articles

Abstract 5687: Integrative -omics analysis to identify drug targets for ccRCC immunotherapy

Anna Reustle, Moreno Di Marco, Florian Büttner, Stefan Winter, Siarhei Kandabarau, Daniel Kowalewski, Linus Backert, Steffen Rausch, Joerg Hennenlotter, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Jens Bedke, Stefan Stevanovic, Matthias Schwab, Elke Schaeffeler
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5687.
https://doi.org/10.1158/1538-7445.AM2018-5687
Published: 01 July 2018
View articletitled, Abstract 5687: Integrative -omics analysis to identify drug targets for ccRCC immunotherapy
Journal Articles

Abstract CT057: Phase I trial to evaluate the feasibility and safety of an individualized peptide vaccine of unmodified cancer antigens: PepIVAC-01

Sebastian Haen, Markus W. Löffler, Oliver Kohlbacher, Sven Nahnsen, Christopher Mohr, Monika Stieglbaueren, Patricia Hrstic, Luigi Buonaguro, Peter Martus, Maik Häntschel, Cécile Gouttefangeas, Stefan Beckert, Alfred Königsrainer, Stefan Stevanovic, Lothar Kanz, Hans-Georg Rammensee
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT057.
https://doi.org/10.1158/1538-7445.AM2018-CT057
Published: 01 July 2018
View articletitled, Abstract CT057: Phase I trial to evaluate the feasibility and safety of an individualized peptide vaccine of unmodified cancer antigens: PepIVAC-01
Journal Articles

Abstract 5824: MHC class I immunogenicity and novel tumor antigen discovery in neuroblastoma

Mark Yarmarkovich, Moreno Di Marco, Olivia Padovan, Jenna Lobby, Laurence Eisenlohr, Dimitrios Monos, Stefan Stevanovic, John M. Maris
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5824.
https://doi.org/10.1158/1538-7445.AM2017-5824
Published: 01 July 2017
View articletitled, Abstract 5824: MHC class I immunogenicity and novel tumor antigen discovery in neuroblastoma
Journal Articles

Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma

Norbert Hilf, Katrin Frenzel, Sabrina Kuttruff-Coqui, Sandra Heesch, Sebastian Kreiter, Arie Admon, Valesca Bukur, Sjoerd van der Burg, Cecile Gouttefangeas, Judith R. Kroep, Marij Schoenmaekers-Welters, Jordi Piro, Berta Ponsati, Hans Skovgaard Poulsen, Ulrik Lassen, Francisco Martinez-Ricarte, Jordi Rodon, Juan Sahuquillo, Monika Stieglbauer, Stefan Stevanovic, Per thor Straten, Marco Skardelly, Ghazaleh Tabatabai, Michael Platten, David Capper, Andreas von Deimling, Valérie Dutoit, Hideho Okada, Christian Ottensmeier, Randi Kristina Feist, Jens Fritsche, Karoline Laske, Peter Lewandrowski, Martin Löwer, Regina Mendryzk, Miriam Meyer, Carsten Reinhardt, Bernhard Rössler, Anna Paruzynski, Nina Pawlowski, Colette Song, Stevermann Lea, Toni Weinschenk, Christoph Huber, Hans-Georg Rammensee, Pierre-Yves Dietrich, Wick Wolfgang, Ugur Sahin, Harpreet Singh-Jasuja
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2654.
https://doi.org/10.1158/1538-7445.AM2016-2654
Published: 15 July 2016
View articletitled, Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma
Journal Articles

Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide

Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, Anna Pluzanska, Cezary Szczylik, Michael Staehler, Wolfram Brugger, Pierre-Yves Dietrich, Norbert Hilf, Oliver Schoor, Jens Fritsche, Andrea Mahr, Regina Mendrzyk, Dominik Maurer, Verona Vass, Claudia Trautwein, Peter Lewandrowski, Christian Flohr, Heike Pohla, Janusz J. Stanczak, Vincenzo Bronte, Susanna Mandruzzato, Tilo Biedermann, Graham Pawelec, Evelyna Derhovanessian, Hisakazu Yamagishi, Tsuneharu Miki, Fumiya Hongo, Natsuki Takaha, Kosei Hirakawa, Hiroaki Tanaka, Stefan Stevanovic, Hans-Georg Rammensee, Jürgen Frisch, Andrea Mayer-Mokler, Alexandra Kirner, James Finke, Brian Rini, Carsten Reinhardt, Harpreet Singh
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5365.
https://doi.org/10.1158/1538-7445.AM2012-5365
Published: 15 April 2012
View articletitled, Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide
Journal Articles

Tumor-Associated MICA Is Shed by ADAM Proteases

Inja Waldhauer, Dennis Goehlsdorf, Friederike Gieseke, Toni Weinschenk, Mareike Wittenbrink, Andreas Ludwig, Stefan Stevanovic, Hans-Georg Rammensee, Alexander Steinle
Journal: Cancer Research
Cancer Res (2008) 68 (15): 6368–6376.
https://doi.org/10.1158/0008-5472.CAN-07-6768
Published: 01 August 2008
View articletitled, Tumor-Associated MICA Is Shed by ADAM Proteases
Open the PDF for Tumor-Associated MICA Is Shed by ADAM Proteases in another window
Includes: Supplementary data
Journal Articles

A novel MHC-associated Proteinase 3 peptide isolated from primary CML cells further supports the significance of this antigen for immunotherapy of myeloid leukemias

Ashley Knights, Andreas Weinzierl, Thomas Flad, Stefan Stevanovic, Ludmila Müller, Graham P. Pawelec
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 525.
Published: 15 April 2006
View articletitled, A novel MHC-associated Proteinase 3 peptide isolated from primary CML cells further supports the significance of this antigen for immunotherapy of myeloid leukemias
Journal Articles

Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

Susanne M. Schmidt, Kerstin Schag, Martin R. Müller, Toni Weinschenk, Silke Appel, Oliver Schoor, Markus M. Weck, Frank Grünebach, Lothar Kanz, Stefan Stevanovic, Hans-Georg Rammensee, Peter Brossart
Journal: Cancer Research
Cancer Res (2004) 64 (3): 1164–1170.
https://doi.org/10.1158/0008-5472.CAN-03-2538
Published: 10 February 2004
View articletitled, Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis
Open the PDF for Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis in another window
Journal Articles

Expression of the Proteasome Activator PA28 Rescues the Presentation of a Cytotoxic T Lymphocyte Epitope on Melanoma Cells

Yuansheng Sun, Alice J. A. M. Sijts, Mingxia Song, Katharina Janek, Alexander K. Nussbaum, Sylvie Kral, Markus Schirle, Stefan Stevanovic, Annette Paschen, Hansjörg Schild, Peter-M. Kloetzel, Dirk Schadendorf
Journal: Cancer Research
Cancer Res (2002) 62 (10): 2875–2882.
Published: 01 May 2002
View articletitled, Expression of the Proteasome Activator PA28 Rescues the Presentation of a Cytotoxic T Lymphocyte Epitope on Melanoma Cells
Open the PDF for Expression of the Proteasome Activator PA28 Rescues the Presentation of a Cytotoxic T Lymphocyte Epitope on Melanoma Cells in another window
Journal Articles

A MAGE-A1 HLA-A*0201 Epitope Identified by Mass Spectrometry

Steve Pascolo, Markus Schirle, Brigitte Gückel, Tilman Dumrese, Susanne Stumm, Simone Kayser, Arnaud Moris, Diethelm Wallwiener, Hans-Georg Rammensee, Stefan Stevanovic
Journal: Cancer Research
Cancer Res (2001) 61 (10): 4072–4077.
Published: 01 May 2001
View articletitled, A MAGE-A1 HLA-A*0201 Epitope Identified by Mass Spectrometry
Open the PDF for A MAGE-A1 HLA-A*0201 Epitope Identified by Mass Spectrometry in another window
Journal Articles

Generation of Survivin-specific CD8+ T Effector Cells by Dendritic Cells Pulsed with Protein or Selected Peptides

Marc Schmitz, Petra Diestelkoetter, Bernd Weigle, Florian Schmachtenberg, Stefan Stevanovic, Detlef Ockert, Hans-Georg Rammensee, Ernst Peter Rieber
Journal: Cancer Research
Cancer Res (2000) 60 (17): 4845–4849.
Published: 01 September 2000
View articletitled, Generation of Survivin-specific CD8+ T Effector Cells by Dendritic Cells Pulsed with Protein or Selected Peptides
Open the PDF for Generation of Survivin-specific CD8+ T Effector Cells by Dendritic Cells Pulsed with Protein or Selected Peptides in another window
Journal Articles

Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes

Peter Brossart, Gernot Stuhler, Thomas Flad, Stefan Stevanovic, Hans-Georg Rammensee, Lothar Kanz, Wolfram Brugger
Journal: Cancer Research
Cancer Res (1998) 58 (4): 732–736.
Published: 01 February 1998
View articletitled, Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes
Open the PDF for Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes in another window